We are live on ! Find out more
HURA

TuHURA Biosciences

50 hedge funds and large institutions have $14.2M invested in TuHURA Biosciences in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 13 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,200% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 1

600% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 4

85% more funds holding

Funds holding: 2750 (+23)

21% more capital invested

Capital invested by funds: $11.8M → $14.2M (+$2.44M)

5.98% more ownership

Funds ownership: 8.64%14.63% (+6%)

Holders
50
Holders Change
+23
Holders Change %
+85.19%
% of All Funds
0.66%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
28
Increased
13
Reduced
1
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$4.98M +$1.21M +358,707 +19%
BlackRock
2
BlackRock
New York
$2.98M +$3.26M +964,029 +258%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$1.3M +$1.04M +307,260 +111%
Fifth Third Bancorp
4
Fifth Third Bancorp
Ohio
$1.06M
UBS Group
5
UBS Group
Switzerland
$571K +$486K +143,869 +128%
Bank of New York Mellon
6
Bank of New York Mellon
New York
$562K +$852K +252,109 New
State Street
7
State Street
Massachusetts
$509K +$668K +197,574 +641%
Northern Trust
8
Northern Trust
Illinois
$449K +$486K +143,966 +251%
AWM
9
Apollon Wealth Management
South Carolina
$257K +$1.18K +348 +0.3%
SEM
10
Suncoast Equity Management
Florida
$233K +$14.9K +4,412 +4%
Charles Schwab
11
Charles Schwab
California
$176K +$216K +64,032 +427%
Barclays
12
Barclays
United Kingdom
$108K +$163K +48,284 New
New York State Common Retirement Fund
13
New York State Common Retirement Fund
New York
$97.5K +$148K +43,700 New
Marshall Wace
14
Marshall Wace
United Kingdom
$79.3K +$120K +35,571 New
Morgan Stanley
15
Morgan Stanley
New York
$76.1K +$75.3K +22,298 +189%
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
$74.9K +$66.9K +19,801 +144%
N
17
Nuveen
North Carolina
$74.9K +$113K +33,575 New
HWMG
18
Hurlow Wealth Management Group
Indiana
$70.1K
Deutsche Bank
19
Deutsche Bank
Germany
$57.5K +$87K +25,765 New
RhumbLine Advisers
20
RhumbLine Advisers
Massachusetts
$55.2K +$83.7K +24,776 New
I
21
INVST
Indiana
$52.2K +$14.9K +4,400 +23%
WAM
22
Warberg Asset Management
Illinois
$44.8K +$67.6K +20,000 New
Wells Fargo
23
Wells Fargo
California
$33.6K +$44.9K +13,275 +738%
Mirae Asset Global ETFs Holdings
24
Mirae Asset Global ETFs Holdings
Hong Kong
$31.2K +$47.3K +13,987 New
MC
25
Merck & Co
New Jersey
$31.1K +$47.1K +13,950 New

HURA Hedge Fund Activity: Q2 2025 in Review

50 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q2 2025, worth a combined $14.2M — up 21% from $11.8M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new HURA positions and 4 closed out — a net gain of 24 holders — while 13 added to existing stakes and 1 trimmed.

The largest buyer was BlackRock, adding an estimated $3.26M. The largest seller was Jane Street, exiting entirely with an estimated $69.1K sold.

  • 50 institutional investors held TuHURA Biosciences (HURA) as of Q2 2025, up from 27 in Q1 2025.
  • Funds reported $14.2M of TuHURA Biosciences stock for Q2 2025, up 21% quarter-over-quarter.
  • 28 funds opened new TuHURA Biosciences positions in Q2 2025 and 4 closed out, a net change of +24 holders.
  • The largest TuHURA Biosciences buyer in Q2 2025 was BlackRock, an estimated $3.26M added.
  • The largest TuHURA Biosciences seller in Q2 2025 was Jane Street, an estimated $69.1K sold.

Based on aggregated 13F filings for Q2 2025.